enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Avacincaptad pegol - Wikipedia

    en.wikipedia.org/wiki/Avacincaptad_pegol

    Avacincaptad pegol, sold under the brand name Izervay, is a medication used for the treatment of age-related macular degeneration. [1] Avacincaptad pegol is a complement inhibitor. [1] Avacincaptad pegol was approved for medical use in the United States in August 2023. [2] [3] [4]

  3. Ipilimumab - Wikipedia

    en.wikipedia.org/wiki/Ipilimumab

    Ipilimumab, in combination with nivolumab, is indicated for the treatment of adults and adolescents twelve years and older with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.

  4. Crizotinib - Wikipedia

    en.wikipedia.org/wiki/Crizotinib

    Crizotinib is indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) or relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. [ 2 ] [ 3 ] It is also indicated for the treatment of unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive ...

  5. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology (immuno-oncology) and a growing subspecialty of oncology.

  6. Pegcetacoplan - Wikipedia

    en.wikipedia.org/wiki/Pegcetacoplan

    Pegcetacoplan is the first treatment for paroxysmal nocturnal hemoglobinuria that binds to and inhibits complement protein C3. [9] Pegcetacoplan was approved for medical use in the United States in May 2021. [9] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [16]

  7. GSK's blood cancer drug meets primary goal in late-stage trial

    www.aol.com/news/gsk-says-blood-cancer-drug...

    The drug belongs to a promising category of treatments called antibody-drug conjugates, which are engineered antibodies that bind to tumour cells and then release cell-killing chemicals.

  8. Tinlarebant - Wikipedia

    en.wikipedia.org/wiki/Tinlarebant

    Tinlarebant is a investigational new drug that is being evaluated to treat dry macular degeneration and Stargardt disease. [1] It is a retinol binding protein 4 antagonist. [ 2 ]

  9. ‘This Weight Loss Drug Helped My Mental Health Way ... - AOL

    www.aol.com/weight-loss-drug-helped-mental...

    “GLP-1 medications impact all of the neurotransmitters in the brain associated with mental health—norepinephrine, serotonin, and dopamine,” says Sue Decotiis, MD, a weight loss doctor based ...